Isthmus Partners LLC lifted its holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) by 4.7% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 34,347 shares of the biotechnology company’s stock after purchasing an additional 1,530 shares during the period. Isthmus Partners […]